AU2020202331A1 — Therapeutic compounds useful for the prophylactic or therapeutic treatment of an HIV virus infection
Assigned to Gilead Sciences Inc · Expires 2020-04-23 · 6y expired
What this patent protects
l\Interwov \NRPortbl\DCC\VZS\20024752 L.dcx-3262020 ABSTRACT The present disclosure relates to a compound of formula (a), (b), (Ila), and (Ilb): FE F F F \N F IN H F I N C1 0 ~ H ON N N-N O% F 0%:S-- F F 0 (1a) FF F F F N F F \yN C1I O N N, N-N O F F F O (…
USPTO Abstract
l\Interwov \NRPortbl\DCC\VZS\20024752 L.dcx-3262020 ABSTRACT The present disclosure relates to a compound of formula (a), (b), (Ila), and (Ilb): FE F F F \N F IN H F I N C1 0 ~ H ON N N-N O% F 0%:S-- F F 0 (1a) FF F F F N F F \yN C1I O N N, N-N O F F F O (Tb) F F F F IN FH 0 H A NN L F O I0 0 (11a) H:\Intewoven\NRPrtbl\DCC\VZS\20024752_.dex-3/26/2020 F F . F F N N F H F 1 N CI 0I H A I N, S N-N O F O 0 (Ib) which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.